Video: CFO Simon Dingemans on GSK's Q2 Results

Published on: 

July 30, 2015.

In this video

, GlaxoSmithKline CFO Simon Dingemans relays the company's Q2 2015 results, rhe first since the Novartis transaction closed.   Despite a slide in the sales of lung drug Advair and lower profit margins following a business revamp, Dingemans says sales rose during the period and that newly acquired businesses are performing in line with expectations.